| Literature DB >> 30208045 |
Kendy Tzu-Yun Teng1, Brecht Devleesschauwer2,3, Charline Maertens De Noordhout4, Peter Bennett1, Paul D McGreevy1, Po-Yu Chiu5, Jenny-Ann L M L Toribio1, Navneet K Dhand1.
Abstract
Currently, separate measures are used to estimate the impact of animal diseases on mortality and animal welfare. This article introduces a novel metric, the Welfare-Adjusted Life Year (WALY), to estimate disease impact by combining welfare compromise and premature death components. Adapting the Disability-Adjusted Life Year approach used in human health audits, we propose WALY as the sum of a) the years lived with impaired welfare due to a particular cause and b) the years of life lost due to the premature death from the same cause. The years lived with impaired welfare are the product of the average duration of each welfare impediment, reflecting the actual condition that compromises animal welfare, the probability of an incident case developing and impaired welfare weights, representing the degree of impaired welfare. The years of life lost are calculated using the standard expected lifespan at the time of premature death. To demonstrate the concept, we estimated WALYs for 10 common canine diseases, namely mitral valve disease, dilated cardiomyopathy, chronic kidney disease, diabetes mellitus, atopic dermatitis, splenic haemangiosarcoma, appendicular osteosarcoma, cranial cruciate ligament disease, thoracolumbar intervertebral disc disease and cervical spondylomyelopathy. A survey of veterinarians (n = 61) was conducted to elicit impaired welfare weights for 35 welfare impediments. Paired comparison was the primary method to elicit weights, whereas visual analogue scale and time trade-off approaches rescaled these weights onto the desired scale, from 0 (the optimal welfare imaginable) to 1 (the worst welfare imaginable). WALYs for the 10 diseases were then estimated using the impaired welfare weights and published epidemiological data on disease impacts. Welfare impediment "amputation: one limb" and "respiratory distress" had the lowest and highest impaired welfare weights at 0.134 and 0.796, rescaled with a visual analogue scale, and 0.117 and 0.857, rescaled with time trade-off. Among the 10 diseases, thoracolumbar intervertebral disc disease and atopic dermatitis had the smallest and greatest adverse impact on dogs with WALYs at 2.83 (95% UI: 1.54-3.94) and 9.73 (95% uncertainty interval [UI]: 7.17-11.8), respectively. This study developed the WALY metric and demonstrated that it summarises welfare compromise as perceived by humans and total impact of diseases in individual animals. The WALY can potentially be used for prioritisation of disease eradication and control programs, quantification of population welfare and longitudinal surveillance of animal welfare in companion animals and may possibly be extended to production animals.Entities:
Mesh:
Year: 2018 PMID: 30208045 PMCID: PMC6135394 DOI: 10.1371/journal.pone.0202580
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Sequelae and welfare impediments identified for the ten diseases included in WALY study.
| Disease | Disease sequela | Welfare impediment |
|---|---|---|
| Mitral valve disease | Mitral valve disease with signs of heart failure | Mild-moderate heart failure (with treatment) |
| Severe heart failure (with treatment) | ||
| Frequent veterinary visits (for fearful dogs) | ||
| Death | Death | |
| Dilated cardiomyopathy | Dilated cardiomyopathy with signs of heart failure | Mild-moderate heart failure (with treatment) |
| Severe heart failure (with treatment) | ||
| Frequent veterinary visits (for fearful dogs) | ||
| Death | Death | |
| Chronic kidney disease | Chronic kidney disease | Vomiting: two times or more a day |
| Diarrhoea: two times or more a day | ||
| Polyuria and polydipsia | ||
| Anaemia: moderate | ||
| Lethargy and loss of appetite | ||
| Death | Death | |
| Diabetes mellitus | Diabetes mellitus: pre-diagnosis | Polyuria and polydipsia |
| Severe vision impairment and blindness | ||
| Anaemia: mild | ||
| Abdominal pain or discomfort | ||
| Diabetes mellitus: stable phase | Frequent veterinary visits (for fearful dogs) | |
| Severe vision impairment and blindness | ||
| Abdominal pain or discomfort | ||
| Frequent subcutaneous injections by carers at home | ||
| Diabetic ketoacidosis | Vomiting: two times or more a day | |
| Diarrhoea: two times or more a day | ||
| Lethargy and loss of appetite | ||
| Polyuria and polydipsia | ||
| Anaemia: mild | ||
| Abdominal pain or discomfort | ||
| Respiratory distress | ||
| Death | Death | |
| Atopic dermatitis | Atopic dermatitis | Pruritus and discomfort: mild |
| Pruritus and discomfort: moderate | ||
| Pruritus and discomfort: severe | ||
| Frequent veterinary visits (for fearful dogs) | ||
| Splenic haemangiosarcoma | Splenic haemangiosarcoma: pre-diagnosis | Abdominal pain or discomfort |
| Cancer: lung metastasis with/without having metastasis in other parts of the body | ||
| Cancer: diagnosis and primary therapy | Cancer: diagnosis and primary therapy | |
| Frequent veterinary visits (for fearful dogs) | ||
| Cancer: lung metastasis with/without having metastasis in other parts of the body | Cancer: lung metastasis with/without having metastasis in other parts of the body | |
| Abdominal pain or discomfort | ||
| Frequent veterinary visits (for fearful dogs) | ||
| Death | Death | |
| Appendicular osteosarcoma | Osteosarcoma: pre-diagnosis | Musculoskeletal problems: one limb, severe |
| Cancer: diagnosis and primary therapy | Cancer: diagnosis and primary therapy | |
| Amputation: one limb | ||
| Frequent veterinary visits (for fearful dogs) | ||
| Cancer: lung metastasis with/without having metastasis in other parts of the body | Cancer: lung metastasis with/without having metastasis in other parts of the body | |
| Amputation: one limb | ||
| Frequent veterinary visits (for fearful dogs) | ||
| Death | Death | |
| Cranial cruciate ligament disease | Cranial cruciate ligament disease: pre-diagnosis | Musculoskeletal problems: one limb, mild |
| Musculoskeletal problems: one limb, moderate | ||
| Musculoskeletal problems: one limb, severe | ||
| Cranial cruciate ligament disease: recovery phase | Musculoskeletal problems: one limb, mild | |
| Musculoskeletal problems: one limb, moderate | ||
| Musculoskeletal problems: one limb, severe | ||
| Cranial cruciate ligament disease: stable phase | Musculoskeletal problems: one limb, mild | |
| Musculoskeletal problems: one limb, moderate | ||
| Musculoskeletal problems: one limb, severe | ||
| Thoracolumbar intervertebral disc disease | Thoracolumbar intervertebral disc disease: pre-diagnosis | Spinal hyperesthesia: mild |
| Spinal hyperesthesia: more severe | ||
| Ataxia, paraparesis or tetraparesis | ||
| Non-ambulatory paraparesis or paraplegia | ||
| Urinary incontinence (upper motor neuron) | ||
| Urinary incontinence (lower motor neuron) | ||
| Thoracolumbar intervertebral disc disease: recovery phase | Spinal hyperesthesia: mild | |
| Ataxia, paraparesis or tetraparesis | ||
| Non-ambulatory paraparesis or paraplegia | ||
| Urinary incontinence (upper motor neuron) | ||
| Urinary incontinence (lower motor neuron) | ||
| Thoracolumbar intervertebral disc disease: stable phase | Spinal hyperesthesia: mild | |
| Ataxia, paraparesis or tetraparesis | ||
| Non-ambulatory paraparesis or paraplegia | ||
| Urinary incontinence (upper motor neuron) | ||
| Urinary incontinence (lower motor neuron) | ||
| Thoracolumbar intervertebral disc disease: reoccurrence episode | Spinal hyperesthesia: mild | |
| Spinal hyperesthesia: more severe | ||
| Ataxia, paraparesis or tetraparesis | ||
| Non-ambulatory paraparesis or paraplegia | ||
| Urinary incontinence (upper motor neuron) | ||
| Urinary incontinence (lower motor neuron) | ||
| Death | Death | |
| Cervical spondylomyelopathy | Cervical spondylomyelopathy: pre-diagnosis | Spinal hyperesthesia: mild |
| Spinal hyperesthesia: more severe | ||
| Ataxia, paraparesis or tetraparesis | ||
| Non-ambulatory tetraparesis or tetraplegia | ||
| Cervical spondylomyelopathy: recovery phase | Spinal hyperesthesia: mild | |
| Ataxia, paraparesis or tetraparesis | ||
| Non-ambulatory tetraparesis or tetraplegia | ||
| Death | Death |
*The compromise eventuating from frequent veterinary visits reflects aversive procedures and is especially relevant for dogs that are fearful of transport and veterinary personnel, clinics and procedures.
An example of lay descriptions and welfare compromises classified by Five Domains of welfare impediments.
| Welfare impediment | Mild-moderate heart failure (with treatment) | ||
|---|---|---|---|
| Lay description | After longer periods of intense physical activity, Dog X is more likely than usual to experience tiredness, weakness and laboured breathing. As such, the dog exercises and plays somewhat less. Also, the dog sometimes coughs. | ||
| Welfare compromise | Five Domain | Welfare compromises affecting ≥ 50% of the cases | Welfare compromises affecting ≥ 10% but <50% of the cases |
| - Sodium-restricted diet is not provided. | |||
| - Cold weather and night can exacerbate the coughing. | - Hot and humid weather exacerbates the respiratory signs of heart failure. | ||
| - Mild to moderate heart failure | - Weight loss | ||
| - Undertakes somewhat fewer intense physical activities than usual | - Eats less than usual; refuses regular food | ||
| - Some discomfort | - Some loss of appetite | ||
Peer-reviewed articles used for data extraction for the estimation of welfare-adjusted life year for 10 canine diseases on which the current study focused.
| Disease | Average age at diagnosis | Average survival time from time of diagnosis (years) | Probability of an incident case developing and duration of welfare impediments in disease sequelae |
|---|---|---|---|
| Mitral valve disease | Borgarelli et al., 2008 [mean: 10.6 (SD | Borgarelli et al., 2008 [median: 1.63 (range: 0.03–6)] [ | Borgarelli et al., 2008 [ |
| Dilated cardiomyopathy | Martin et al., 2009 [median: 6.67 (IQR | Martin et al., 2009 [median: 0.37 (IQR: 0.08–1.15)] [ | Martin et al., 2009 [ |
| Chronic kidney disease | O'Neill et al., 2013 [median: 12.39 (range: 0.75–19.14)] [ | O'Neill et al., 2013 [median: 0.62 (95% CI | O'Neill et al., 2013 [ |
| Diabetes mellitus | Mattin et al., 2014 [median: 9.9 (range: 3.3–17.4)] [ | Mattin et al., 2014 (median: 1.44) [ | Hess et al., 2000 [ |
| Atopic dermatitis | Saridomichelakis et al., [median: 2.5 (range: 0.17–8)] [ | NA | Rybníček et al., 2009 [ |
| Splenic haemengiosarcoma | Kahn et al., 2013 [median: 9.9 (range: 7–14.1)] [ | Estimated using information from Kahn et al., 2013 [ | Kahn et al., 2013 [ |
| Appendicular osteosarcoma | Bacon et al., 2008 [median: 8 (range: 1.3–13.2)] [ | Bacon et al., 2008 [median: 0.71 (95% CI : 0.48–0.94)] [ | Bacon et al., 2008 [ |
| Cranial cruciate ligament disease | Multiple [ | NA | Cabrera et al., 2008 [ |
| Thoracolumbar intervertebral disc disease | Aikawa et al., 2012 [median: 5 (range: 1.5–14)] [ | Multiple [ | Aikawa et al., 2012 [ |
| Cervical spondylomyelopathy | McKee et al., 1999 [median: 7 (range: 3–11)] [ | Estimated using information from da Costa et al., 2008 [ | Fadda et al., 2013 [ |
1: Decimal place depended on the results in the articles cited.
2: Standard deviation.
3: Interquartile range.
4: Confidence interval.
5: Not applicable.
The impaired welfare weights (IWWs) for five welfare impediments generated by visual analogue scale (VAS) and time trade-off (TTO) ordered from lowest to highest.
| Welfare impediment | IWW (VAS) | IWW (TTO) | ||||
|---|---|---|---|---|---|---|
| Mean | SD | Range | Mean | SD | Range | |
| Cancer: lung metastasis with/without having metastasis in other parts of the body | 0.759 | 0.156 | 0.30–1.00 | 0.858 | 0.166 | 0.30–0.99 |
| Musculoskeletal problems: one limb, mild | 0.414 | 0.169 | 0.05–0.80 | 0.386 | 0.324 | 0.00–0.99 |
| Anaemia: mild | 0.215 | 0.135 | 0.03–0.53 | 0.198 | 0.260 | 0.00–0.95 |
| Respiratory distress | 0.897 | 0.094 | 0.50–1.00 | 0.917 | 0.144 | 0.40–1.00 |
| Diarrhoea: two times or more a day | 0.483 | 0.210 | 0.15–0.98 | 0.480 | 0.326 | 0.00–0.99 |
Legends: IWWs range from 0 (the optimal welfare imaginable) to 1 (the worst welfare imaginable).
1: Standard deviation
The mean impaired welfare weights (IWWs) of subgroups for five welfare impediments generated by visual analogue scale (VAS) and time trade-off (TTO).
| Name | Gender | Age (year) | Graduation year | Interest in small animal medicine/surgery | Working with livestock | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Visual analogue scale | Female | Male | <36 | ≥36 | ≥2005 | <2005 | No | Yes | No | Yes |
| Cancer: lung metastasis with/without having metastasis in other parts of the body | 0.78 | 0.72 | 0.79 | 0.73 | 0.81 | 0.70 | 0.77 | 0.75 | 0.77 | 0.74 |
| Musculoskeletal problems: one limb, mild | 0.44 | 0.36 | 0.42 | 0.41 | 0.43 | 0.40 | 0.39 | 0.44 | 0.46 | 0.31 |
| Anaemia: mild | 0.25 | 0.14 | 0.21 | 0.22 | 0.22 | 0.21 | 0.24 | 0.20 | 0.22 | 0.21 |
| Respiratory distress | 0.91 | 0.87 | 0.90 | 0.89 | 0.90 | 0.89 | 0.92 | 0.88 | 0.92 | 0.86 |
| Diarrhoea: two times or more a day | 0.50 | 0.45 | 0.46 | 0.51 | 0.48 | 0.48 | 0.55 | 0.42 | 0.46 | 0.53 |
| Cancer: lung metastasis with/without having metastasis in other parts of the body | 0.86 | 0.85 | 0.89 | 0.82 | 0.89 | 0.82 | 0.86 | 0.85 | 0.87 | 0.81 |
| Musculoskeletal problems: one limb, mild | 0.40 | 0.36 | 0.47 | 0.31 | 0.45 | 0.31 | 0.3 | 0.46 | 0.41 | 0.27 |
| Anaemia: mild | 0.20 | 0.19 | 0.23 | 0.17 | 0.22 | 0.17 | 0.18 | 0.21 | 0.21 | 0.13 |
| Respiratory distress | 0.91 | 0.94 | 0.96 | 0.88 | 0.96 | 0.87 | 0.93 | 0.90 | 0.92 | 0.89 |
| Diarrhoea: two times or more a day | 0.53 | 0.37 | 0.56 | 0.40 | 0.56 | 0.39 | 0.45 | 0.50 | 0.50 | 0.39 |
Legends: IWWs range from 0 (the optimal welfare imaginable) to 1 (the worst welfare imaginable).
* Significant difference between the two subgroups based on P-value <0.05.
Fig 1Comparison of impaired welfare weights anchored by visual analogue scale (black) and time trade-off (grey).
Fig 1(a) displays the models using all the five anchoring welfare impediments, and the models in (b) and (c) excluded “respiratory distress” and “cancer: lung metastasis with/without having metastasis in other parts of the body”, respectively.
Impaired welfare weights (IWWs) for the 35 welfare impediments.
| Welfare impediment | IWW (VAS) | IWW (TTO) |
|---|---|---|
| Mild-moderate heart failure (with treatment) | 0.357 (0.305–0.411) | 0.337 (0.304–0.372) |
| Severe heart failure (with treatment) | 0.646 (0.524–0.755) | 0.655 (0.575–0.728) |
| Cancer: diagnosis and primary therapy | 0.728 (0.599–0.833) | 0.752 (0.673–0.821) |
| Cancer: lung metastasis with/without having metastasis in other parts of the body | 0.757 (0.679–0.824) | 0.857 (0.823–0.887) |
| Musculoskeletal problems: one limb, mild | 0.387 (0.332–0.444) | 0.368 (0.332–0.405) |
| Musculoskeletal problems: one limb, moderate | 0.760 (0.637–0.858) | 0.793 (0.720–0.854) |
| Musculoskeletal problems: one limb, severe | 0.786 (0.675–0.872) | 0.829 (0.767–0.879) |
| Severe vision impairment and blindness | 0.602 (0.490–0.707) | 0.604 (0.530–0.675) |
| Overweight | 0.504 (0.420–0.588) | 0.494 (0.438–0.550) |
| Obesity | 0.406 (0.348–0.467) | 0.389 (0.350–0.428) |
| Spinal hyperesthesia: mild | 0.777 (0.661–0.868) | 0.815 (0.749–0.870) |
| Spinal hyperesthesia: more severe | 0.740 (0.612–0.843) | 0.767 (0.689–0.833) |
| Ataxia, paraparesis or tetraparesis | 0.504 (0.420–0.587) | 0.494 (0.437–0.549) |
| Non-ambulatory paraparesis or paraplegia | 0.740 (0.614–0.843) | 0.767 (0.691–0.833) |
| Non-ambulatory paraparesis or paraplegia: on wheelchair some hours a day | 0.641 (0.520–0.750) | 0.649 (0.570–0.722) |
| Non-ambulatory tetraparesis or tetraplegia | 0.795 (0.698–0.872) | 0.846 (0.795–0.888) |
| Urinary incontinence (upper motor neuron) | 0.747 (0.621–0.848) | 0.776 (0.700–0.840) |
| Urinary incontinence (lower motor neuron) | 0.783 (0.670–0.871) | 0.825 (0.762–0.876) |
| Anaemia: mild | 0.224 (0.163–0.295) | 0.203 (0.165–0.247) |
| Anaemia: moderate | 0.693 (0.565–0.803) | 0.711 (0.629–0.783) |
| Anaemia: severe | 0.795 (0.696–0.872) | 0.845 (0.793–0.888) |
| Pruritus and discomfort: mild | 0.560 (0.459–0.657) | 0.556 (0.489–0.621) |
| Pruritus and discomfort: moderate | 0.748 (0.623–0.849) | 0.778 (0.702–0.842) |
| Pruritus and discomfort: severe | 0.750 (0.624–0.850) | 0.780 (0.704–0.843) |
| Respiratory distress | 0.796 (0.713–0.865) | 0.857 (0.815–0.892) |
| Polyuria and polydipsia | 0.332 (0.282–0.386) | 0.312 (0.279–0.347) |
| Vomiting: two times or more a day | 0.796 (0.709–0.866) | 0.855 (0.811–0.892) |
| Diarrhoea: two times or more a day | 0.502 (0.418–0.586) | 0.492 (0.436–0.548) |
| Abdominal pain or discomfort | 0.741 (0.613–0.844) | 0.768 (0.691–0.835) |
| Lethargy and loss of appetite | 0.736 (0.609–0.840) | 0.763 (0.685–0.830) |
| Fever | 0.796 (0.700–0.871) | 0.848 (0.799–0.889) |
| Amputation: one limb | 0.134 (0.072–0.223) | 0.117 (0.078–0.168) |
| Frequent veterinary visits (for fearful dogs) | 0.244 (0.185–0.310) | 0.223 (0.186–0.264) |
| Frequent subcutaneous injections by carers at home | 0.555 (0.455–0.652) | 0.551 (0.484–0.616) |
| Death | 0.562 (0.460–0.659) | 0.558 (0.491–0.624) |
Legends: IWWs range from 0 (the optimal welfare imaginable) to 1 (the worst welfare imaginable). The two sets of IWWs were anchored by visual analogue scale (VAS) and time trade-off (TTO), respectively, after excluding the anchoring welfare impediment “respiratory distress” in the model building process.
Years lived with impaired welfare (YLIWs), non-weighted and weighted (with the impaired welfare weight of death) years of life lost (YLLs) due to premature death and non-weighted and weighted welfare-adjusted life years (WALY) for 10 canine diseases.
| Variable | YLIW | Non-weighted YLLs | Non-weighted WALYs | Weighted YLLs | Weighted WALYs |
|---|---|---|---|---|---|
| Mitral valve disease | 0.81 (0.14–1.70) | 3.11 (1.10–7.08) | 3.91 (1.80–7.67) | 1.73 (0.60–3.98) | 2.54 (1.21–4.61) |
| Dilated cardiomyopathy | 0.31 (0.10–0.60) | 7.09 (5.85–8.33) | 7.40 (6.21–8.60) | 3.96 (3.14–4.84) | 4.27 (3.47–5.13) |
| Chronic kidney disease | 0.58 (0.29–0.84) | 3.52 (1.10–8.76) | 4.11 (1.59–9.33) | 1.97 (0.59–4.92) | 2.55 (1.08–5.51) |
| Diabetes mellitus | 1.00 (0.90–1.17) | 3.62 (1.13–7.34) | 4.62 (2.15–8.34) | 2.02 (0.64–4.13) | 3.02 (1.63–5.12) |
| Atopic dermatitis | 9.73 (7.17–11.8) | 0.00 (0.00–0.00) | 9.73 (7.17–11.8) | 0.00 (0.00–0.00) | 9.73 (7.17–11.8) |
| Splenic haemangiosarcoma | 0.49 (0.46–0.52) | 4.36 (2.59–6.23) | 4.85 (3.08–6.72) | 2.43 (1.42–3.55) | 2.93 (1.92–4.04) |
| Appendicular osteosarcoma | 0.94 (0.67–1.30) | 6.00 (2.90–9.90) | 6.94 (3.83–10.84) | 3.35 (1.60–5.59) | 4.29 (2.52–6.55) |
| Cranial cruciate ligament disease | 3.47 (2.39–4.58) | 0.00 (0.00–0.00) | 3.47 (2.39–4.58) | 0.00 (0.00–0.00) | 3.47 (2.39–4.58) |
| Thoracolumbar intervertebral disc disease | 2.51 (1.37–3.51) | 0.32 (0.16–0.45) | 2.83 (1.54–3.94) | 0.18 (0.09–0.26) | 2.69 (1.47–3.75) |
| Cervical spondylomyelopathy | 2.23 (1.67–3.17) | 4.26 (2.28–6.63) | 6.49 (4.55–8.76) | 2.38 (1.26–3.76) | 4.61 (3.40–6.00) |
The impaired welfare weights were anchored by time trade-off (TTO) after excluding the impaired welfare weight of welfare impediment “respiratory distress” in the model building process.
Fig 2The composition of non-weighted welfare-adjusted life years for 10 canine diseases.
The impaired welfare weights were anchored by time trade-off after excluding the impaired welfare weight of welfare impediment “respiratory distress” in the model building process. YLIWs: Years lived with impaired welfare; YLLs: years of life lost; AD: atopic dermatitis; DCM: dilated cardiomyopathy; AO: appendicular osteosarcoma; CSM: cervical spondylomyelopathy; SH: splenic haemangiosarcoma; DM: diabetes mellitus; CKD: chronic kidney disease; MVD: mitral valve disease; CCLD: cranial cruciate ligament disease; TIDD: thoracolumbar intervertebral disc disease.